Cargando…

Correction: Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma

Detalles Bibliográficos
Autores principales:	Wu, Jian, Shen, Shun-Li, Chen, Bin, Nie, Jing, Peng, Bao-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942234/ https://www.ncbi.nlm.nih.gov/pubmed/35320325 http://dx.doi.org/10.1371/journal.pone.0265938

Ejemplares similares

Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2014)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

Correction: Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein
por: Sheng, Weiwei, et al.
Publicado: (2022)

Numb downregulation suppresses cell growth and is associated with a poor prognosis of human hepatocellular carcinoma
por: XIE, CHENGZHI, et al.
Publicado: (2015)

Correction: Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis
por: Mah, Way-Champ, et al.
Publicado: (2016)

Correction to: Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer
por: Yao, Bing, et al.
Publicado: (2022)

Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection
por: Shen, Shun-Li, et al.
Publicado: (2014)

Correction: Th1(high) in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC
por: Jian, Huang, et al.
Publicado: (2017)

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2023)

Correction to: MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis
por: Li, Yue, et al.
Publicado: (2018)

Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2020)

PSMB5 overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Correction: High Expression of KIF26B in Breast Cancer Associates with Poor Prognosis
por: Wang, Qun, et al.
Publicado: (2013)

Correction: YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
por: Xia, Yan, et al.
Publicado: (2016)

Decreased Expression of GATA2 Promoted Proliferation, Migration and Invasion of HepG2 In Vitro and Correlated with Poor Prognosis of Hepatocellular Carcinoma
por: Li, Yi-Wei, et al.
Publicado: (2014)

Correction to: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
por: Lv, Lei, et al.
Publicado: (2020)

High NRBP1 expression promotes proliferation and correlates with poor prognosis in bladder cancer
por: Wu, Qi, et al.
Publicado: (2019)

Correction: Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis
por: Xie, Yongpeng, et al.
Publicado: (2019)

Correction: Interleukin-17 receptor C gene polymorphism reduces treatment effect and promotes poor prognosis of ischemic stroke
Publicado: (2020)

Correction: Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer
por: Zhan, Yonghao, et al.
Publicado: (2023)

Correction to: Transient ischemic attack presenting as recurrent migratory numbness by seconds: a rare case confirmed by transcranial Doppler micro-emboli monitoring
por: Liu, Xianyue, et al.
Publicado: (2020)

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

Correction to: DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells
por: Li, Weijing, et al.
Publicado: (2023)

UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
por: Guo, Yanjing, et al.
Publicado: (2023)

The role of NUMB/NUMB isoforms in cancer stem cells
por: Choi, Hye Yeon, et al.
Publicado: (2021)

SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
por: Lai, Ssu-Chuan, et al.
Publicado: (2020)

Correction: High LINC01605 expression predicts poor prognosis and promotes tumor progression via upregulation of MMP9 in bladder cancer
Publicado: (2020)

MFAP2 Promotes the Proliferation of Cancer Cells and Is Associated With a Poor Prognosis in Hepatocellular Carcinoma
por: Zhu, Xiang, et al.
Publicado: (2020)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

ncRNAs-mediated high expression of TICRR promotes tumor cell proliferation and migration and is correlated with poor prognosis and tumor immune infiltration of hepatocellular carcinoma
por: He, Ke-Jie, et al.
Publicado: (2022)

WDR5 Promotes Proliferation and Correlates with Poor Prognosis in Oesophageal Squamous Cell Carcinoma
por: Huang, Di, et al.
Publicado: (2020)

Correction to: Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in luminal B breast cancer
por: Katchman, Benjamin A., et al.
Publicado: (2018)

Correction: Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
por: Wang, Dan, et al.
Publicado: (2021)

Correction to: The circular RNA hsa_circ_0001394 promotes hepatocellular carcinoma progression by targeting the miR-527/UBE2A axis
por: Yan, Yu, et al.
Publicado: (2022)

Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters
por: Zhang, Heyun, et al.
Publicado: (2021)

LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma
por: Zhang, Ning, et al.
Publicado: (2022)

Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fn4tv8q0emqavqtcmak5l2fhff